文献速递小儿神经外科与脑积水脑血管病外科

脑室分流特发性正常压力脑积水患者发生硬膜下血肿的危险因素:一项基于注册登记的1457例患者研究

Risk factors for developing subdural hematoma: a registry-based study in 1457 patients with shunted idiopathic normal pressure hydrocephalus.
PubMed 文献 · J Neurosurg · 2020-01-10

基于瑞典脑积水质量登记系统,纳入2004—2014年接受分流手术的特发性正常压力脑积水患者1457例,152例(10.4%)发生硬膜下血肿。男性、使用抗血小板药物及术中较低的分流阀开启压力是硬膜下血肿的危险因素;抗虹吸装置未预防硬膜下血肿,但允许使用较低开启压力而不增加硬膜下血肿。

要点

  • 男性较女性硬膜下血肿风险高(OR 2.084,95%CI 1.421-3.058,p<0.001)。
  • 使用抗血小板药物者硬膜下血肿风险高(OR 1.733,95%CI 1.236-2.431,p=0.001)。
  • 硬膜下血肿组术中开启压力较无硬膜下血肿组低5.9 mm H2O(109.6±24.1 vs 115.5±25.4 mm H2O,p=0.009)。

核心结论

  • 男性、抗血小板药物及术中较低的分流阀开启压力是特发性正常压力脑积水分流术后发生硬膜下血肿的危险因素;身体状态与合并症不是危险因素。
  • 抗虹吸装置未预防硬膜下血肿,但使用抗虹吸装置的分流管允许设定较低开启压力而不增加硬膜下血肿。

研究设计与样本

  • 基于瑞典脑积水质量登记系统的注册登记研究,筛查2004—2014年在瑞典接受分流手术的特发性正常压力脑积水患者,术前及术后3个月记录硬膜下血肿的潜在危险因素,药物处方来自国家药房数据库,比较发生与未发生硬膜下血肿的患者。

主要发现

  • 研究人群共1457例,152例(10.4%)发生硬膜下血肿。
  • 男性发生硬膜下血肿多于女性(OR 2.084,95%CI 1.421-3.058,p<0.001)。
  • 使用血小板聚集抑制剂者发生硬膜下血肿多于未使用者(OR 1.733,95%CI 1.236-2.431,p=0.001)。
  • 硬膜下血肿组术中分流阀开启压力较无硬膜下血肿组低5.9 mm H2O(109.6±24.1 vs 115.5±25.4 mm H2O,p=0.009)。
  • 892例使用了抗虹吸装置,但未预防硬膜下血肿;使用抗虹吸装置的分流管在手术时和随访时的平均开启压力较低,而未导致更多硬膜下血肿。

关键数值与推荐

  • 男性发生硬膜下血肿的OR 2.084(95%CI 1.421-3.058,p<0.001)。
  • 使用血小板聚集抑制剂者发生硬膜下血肿的OR 1.733(95%CI 1.236-2.431,p=0.001)。
  • 硬膜下血肿组术中开启压力109.6±24.1 mm H2O vs 无硬膜下血肿组115.5±25.4 mm H2O(p=0.009)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Subdural hematomas and hygromas (SDHs) are common complications in idiopathic normal pressure hydrocephalus (iNPH) patients with shunts. In this registry-based study, patients with shunted iNPH were screened nationwide to identify perioperative variables that may increase the risk of SDH. METHODS: The Swedish Hydrocephalus Quality Registry was reviewed for iNPH patients who had undergone shunt surgery in Sweden in 2004-2014. Potential risk factors for SDH were recorded preoperatively and 3 months after surgery. Drug prescriptions were identified from a national pharmacy database. Patients who developed SDHs were compared with those without SDHs. RESULTS: The study population consisted of 1457 patients, 152 (10.4%) of whom developed an SDH. Men developed an SDH more often than women (OR 2.084, 95% CI 1.421-3.058, p < 0.001). Patients on platelet aggregation inhibitors developed an SDH more often than those who were not (OR 1.733, 95% CI 1.236-2.431, p = 0.001). At surgery, shunt opening pressures had been set 5.9 mm H2O lower in the SDH group than in the no-SDH group (109.6 ± 24.1 vs 115.5 ± 25.4 mm H2O, respectively, p = 0.009). Antisiphoning devices (ASDs) were used in 892 patients but did not prevent SDH. Mean opening pressures at surgery and the follow-up were lower with shunts with an ASD, without causing more SDHs. No other differences were seen between the groups. CONCLUSIONS: iNPH patients in this study were diagnosed and operated on in routine practice; thus, the results represent everyday care. Male sex, antiplatelet medication, and a lower opening pressure at surgery were risk factors for SDH. Physical status and comorbidity were not. ASD did not prevent SDH, but a shunt with an ASD allowed a lower opening pressure without causing more SDHs.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gasslander J, Sundström N, Eklund A, et al. Risk factors for developing subdural hematoma: a registry-based study in 1457 patients with shunted idiopathic normal pressure hydrocephalus. J Neurosurg. 2020. PMID: 31923893. doi:10.3171/2019.10.JNS191223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。